{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:48:32Z","timestamp":1791607712656,"version":"4.3.4"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004028","name":"Jiangnan University","doi-asserted-by":"publisher","award":["2022ZHZD02"],"award-info":[{"award-number":["2022ZHZD02"]}],"id":[{"id":"10.13039\/501100004028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bmcl.2026.130567","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T23:22:58Z","timestamp":1769901778000},"page":"130567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of cytochrome P450 CYP11A1 inhibitors"],"prefix":"10.1016","volume":"135","author":[{"given":"Dongyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengkai","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130567_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)61947-4","article-title":"Prostate cancer","author":"Attard","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2026.130567_bb0010","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bmcl.2026.130567_bb0015","doi-asserted-by":"crossref","DOI":"10.5694\/mja2.50820","article-title":"Understanding the diagnosis of prostate cancer","author":"Ong","year":"2020","journal-title":"Med. J. Aust."},{"issue":"1","key":"10.1016\/j.bmcl.2026.130567_bb0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bmcl.2026.130567_bb0025","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2007.15.9749","article-title":"Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate Cancer commonly remains hormone driven","author":"Attard","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bmcl.2026.130567_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2014.07.008","article-title":"Strategies for targeting the androgen receptor axis in prostate cancer","author":"Carver","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bmcl.2026.130567_bb0035","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-12-0931","article-title":"Molecular pathways: inhibiting steroid biosynthesis in prostate cancer","author":"Ferraldeschi","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bmcl.2026.130567_bb0040","article-title":"Synthesis of tyrosinase inhibitory kojic acid derivative","author":"Lee","year":"2006","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bmcl.2026.130567_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2011.07.044","article-title":"Potent antimalarial 4-pyridones with improved physico-chemical properties","author":"Bueno","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2026.130567_bb0050","article-title":"Synthesis of kojic acid-derived copper-chelating apoptosis inducing agents","author":"Chen","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bmcl.2026.130567_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2010.10.003","article-title":"Indium(III) chloride catalyzed three-component coupling reaction: a novel synthesis of 2-substituted aryl(indolyl)kojic acid derivatives as potent antifungal and antibacterial agents","author":"Reddy","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2026.130567_bb0060","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-22-0115","article-title":"First-in-class small molecule to inhibit CYP11A1 and steroid hormone biosynthesis","author":"Karimaa","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bmcl.2026.130567_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2024.08.1686","article-title":"1605P Opevesostat (MK-5684\/ODM-208), an oral CYP11A1 inhibitor, in metastatic castration-resistant prostate cancer (mCRPC): updated CYPIDES phase II results","author":"Fizazi","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bmcl.2026.130567_bb0070","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.4_suppl.159","article-title":"MK-5684 (ODM-208), a CYP11A1 inhibitor, in patients with metastatic castration-resistant prostate cancer (mCRPC) with and without AR-LBD mutations: CYPIDES phase 2 results","author":"Fizazi","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bmcl.2026.130567_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2024.08.2237","article-title":"1663TiP CYP11A1 inhibitor Opevesostat (MK-5684) alone or in combination with other therapies for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): the phase I\/II MK-5684-01A substudy","author":"Hussain","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bmcl.2026.130567_bb0080","series-title":"Cytochrome P450 Function and Pharmacological Roles in Inflammation and Cancer","article-title":"Cytochrome P450 in pharmacogenetics: an update","author":"Tornio","year":"2018"},{"issue":"12","key":"10.1016\/j.bmcl.2026.130567_bb0085","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1124\/dmd.30.12.1311","article-title":"Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions","volume":"30","author":"Yuan","year":"2002","journal-title":"Drug Metab. Dispos."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2600034X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2600034X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T12:47:27Z","timestamp":1776602847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2600034X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":17,"alternative-id":["S0960894X2600034X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130567","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of cytochrome P450 CYP11A1 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130567"}}